1) far away from Signing commercial Contract,
2) need more trial to get consistent Better result, this drug for human, not for animal, before get to market need many trails and go through more drug regulation,
3) not far from CR
4) before November SP definitely back to 2.2 or even lower
5) at the stage this company just a big hole, need more money to fill the hole , till really sign the commercial contract if results success
6) for now only people moving the SP is day traders, u should thankful for day trader , because they are the one giving u good moon yesterday, but sorry today they are dumping, more dumping coming after 3 PM
Ann: Immutep presents positive TACTI-mel melanoma trial data, page-83
-
- There are more pages in this discussion • 63 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.020(6.67%) |
Mkt cap ! $464.8M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 32.3¢ | 30.0¢ | $1.040M | 3.328M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 42705 | 2 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |